ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 689627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 689627; 2) Community: the network communities that were significantly associated with the response to NSC 689627; 3) Molecule: the relationships between components within communities and NSC 689627; 4) MDR: the compounds that were significantly associated with the NSC 689627.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0105972823829604 0.30972736
NSC 735030 Null 0.0105972823829604 0.22474185
NSC 736811 Null 0.0105972823829604 0.37646835
NSC 740 Methotrexate 0.0105972823829604 0.52530334
NSC 743528 Null 0.0105972823829604 0.3263484
NSC 744063 Null 0.0105972823829604 0.46746496
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0105972823829604 0.34093784
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0105972823829604 0.33975148
NSC 163027 Diketocoriolin B 0.0119221520283057 0.45953335
NSC 728134 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-5-chloro-2-methoxybenzene 0.0119221520283057 0.4726179
Total:122  Current:47    [First] [Prev] [Next] [Last]